The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 10, 2025 for Raksha Sudhir Valia
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty 100 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Raksha Sudhir Valia, a Person Acting in Concert (PAC) with the promoter group of Sun Pharmaceutical Industries, has pledged 6,50,000 equity shares (about 0.027% of total share capital) on July 4, 2025. The pledge was created in favor of Citicorp Finance (India) Limited as security for a loan facility availed by a third party. After this pledge, her encumbered shares stand at 1,19,90,400 (0.499% of share capital), out of her total holding of 28,830,352 shares (1.20%). This is a routine disclosure under SEBI's takeover regulations to inform exchanges about the encumbrance.
This is a routine regulatory disclosure and a small pledge creation relative to overall shareholding. It is not expected to have any meaningful impact on the stock price. Investors may note that the pledge is for a third-party loan, not the company's own borrowings.